Delivery Order SPE2DB20D2104-SPE2DB24FT11P
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $45,737.71 for Trelegy Ellipta 100-62.5-25 60s, a pharmaceutical product, to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,176.39 firm fixed-price delivery order contract has a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, to the government. The $16,402.09 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2023, with a performance period ending on January 30, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60s pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,804.57, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with an ultimate completion date of September 16, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 200-62.5-25 60s medication. The $13,738.98 firm fixed-price delivery order contract has a period of performance through March 10, 2023. The award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $25,559.68 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 10, 2025, with a completion date of March 11, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $5,275.23 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 23, 2024 with a completion date of April 24, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $17,877.82 and a completion date of October 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,659.73 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, over the period from February 3, 2025 to February 4, 2025. The contract has a ceiling value of $5,578.92 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any special program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT11PDelivery Order
This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,434.87 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 18, 2024, with a completion date of March 19, 2024. This appears to be a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award was not set aside for any socioeconomic category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 3/18/24 |